Back to list

B6TD: A study for people with tardive dyskinesia

University of North Carolina at Chapel Hill


Description

To see if vitamin B6 (pyridoxine) can improve symptoms of tardive dyskinesia.


Keywords:

Eyes, Feet, Hands, Mental Health, Mouth/Nose/Throat, Muscles, Neurological Disorders


Category:

Drug or Biologic
Phase:4

Qualifications

 


Age
18 - 80 years


Gender
Any


Study Population

Adults ages 18-80 who have tardive dyskinesia and have had 3 months of antipsychotic exposure.


Investigator

Fred Jarskog
Clinical Professor
Psychiatry - General

For questions, contact:

Jesi Post
jesi_post@med.unc.edu
(919) 445-0295


Recruitment Period End

September 19, 2020

Location

Primary Location
UNC Chapel Hill
101 Manning Dr # 1, Chapel Hill, NC 27514, USA
Secondary Location
Raleigh
3010 Falstaff Rd, Raleigh, NC 27610, USA

Study Qualifications

Gender Any

Age Range 18 - 80 years

Participant qualification(s) Adults ages 18-80 who have tardive dyskinesia and have had 3 months of antipsychotic exposure.

Not eligible if: Currently being treated with vitamin B6 (pyridoxine).

Number of Visits

    » 7 In person visit(s)

    1 screening visit, 1 baseline visit, 4 regular study visits, and 1 follow-up visit. Procedures include a physical exam, urine and blood tests, questionnaires, and interviews.

    » 0 Remote visit(s)

Participation Period

10 weeks

Compensation

Participants are paid at each study visit, earning up to $225 total. $50 for screening, $50 for baseline, and $25 for each additional study visit. .

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.